Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Description of characteristics, management of care and healthcare direct costs of patients with HR+/HER2- early breast cancer in Italy: a real-world study involving administrative and pathological anatomy databases.
Perrone V, Giacomini E, Sangiorgi D, Tamma A, Giovannitti M, Buzzoni C, Degli Esposti L. Perrone V, et al. Among authors: giovannitti m. Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec;23(9):1077-1085. doi: 10.1080/14737167.2023.2246652. Epub 2023 Aug 28. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 37638590
Analysis of the prevalence of ankylosing spondylitis and treatment patterns and drug utilization among affected patients: an Italian real-world study.
Perrone V, Losi S, Filippi E, Antonelli S, Giovannitti M, Giacomini E, Sangiorgi D, Degli Esposti L. Perrone V, et al. Among authors: giovannitti m. Expert Rev Pharmacoecon Outcomes Res. 2022 Mar;22(2):327-333. doi: 10.1080/14737167.2022.2032663. Epub 2022 Jan 31. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 35057700
Cost-effectiveness analysis of abemaciclib with endocrine therapy (ET) versus ET alone for HR+, HER2-, node-positive, high-risk early breast cancer in Italy.
Davie A, Traoré S, Giovannitti M, Pompilio G, Lambton M, Cakar E, Chatterjee A. Davie A, et al. Among authors: giovannitti m. Glob Reg Health Technol Assess. 2023 Sep 28;10:62-69. doi: 10.33393/grhta.2023.2561. eCollection 2023 Jan-Dec. Glob Reg Health Technol Assess. 2023. PMID: 37811343 Free PMC article.